OPGN currently looks like its in a rising wedge pattern, which usually break downward. I've been in since $1.75, averaged up to about $1.97. With volume it could make another run for the $2.50's, if rejected it could break downward out of the wedge and revisit the $2.10 area. Might get close to a golden cross by that time as well.
Fundamentally, the company has a product similar to that of BNGO, but still awaiting FDA approval. Also, the company's subsidiary has a deal for $160M euros upon approval for use in China(according to Q3 2020 earnings call). the company just did a direct offering and has about $13M in cash. float is only 18.14M shares. If all the pieces come together this could see new 52W highs in the near future.
Fundamentally, the company has a product similar to that of BNGO, but still awaiting FDA approval. Also, the company's subsidiary has a deal for $160M euros upon approval for use in China(according to Q3 2020 earnings call). the company just did a direct offering and has about $13M in cash. float is only 18.14M shares. If all the pieces come together this could see new 52W highs in the near future.